Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: Data from >600 patients in the control arm of the STAMPEDE trial (NCT00268476).
Noel W Clarke
Consultant or Advisory Role - Amgen; Bayer; Janssen; Takeda
Honoraria - Astellas Pharma; Janssen; Takeda
Research Funding - AstraZeneca
Nicholas David James
Consultant or Advisory Role - Amgen; Astellas Pharma; Janssen
Honoraria - Amgen; Astellas Pharma; Bayer; Janssen; Sanofi
Research Funding - Janssen-Cilag; Novartis; Pfizer; Sanofi
Malcolm David Mason
Consultant or Advisory Role - Bristol-Myers Squibb; Johnson & Johnson; Sanofi
Honoraria - Bristol-Myers Squibb; Johnson & Johnson; Sanofi ; Takeda
Daniel M. Aebersold
No relevant relationships to disclose
David Paul Dearnaley
Employment or Leadership Position - Institute of Cancer Research
Consultant or Advisory Role - Janssen-Cilag
Honoraria - Amgen; Astellas Pharma; Janssen; Takeda
Research Funding - Janssen
Johann Sebastian De Bono
Employment or Leadership Position - Institute of Cancer Research
Consultant or Advisory Role - Johnson & Johnson; Sanofi
Honoraria - Astellas Pharma; Johnson & Johnson; Sanofi
Research Funding - Sanofi
Chris Parker
Consultant or Advisory Role - Bayer; BN ImmunoTherapeutics
Honoraria - Astellas Pharma; Bayer; BN ImmunoTherapeutics; Bristol-Myers Squibb; Janssen-Cilag; Sanofi ; Takeda
Mahesh Parmar
Research Funding - Janssen-Cilag; Novartis; Pfizer; Sanofi
Alastair WS Ritchie
Research Funding - Janssen-Cilag; Novartis; Pfizer; Sanofi
J. Martin Russell
No relevant relationships to disclose
Melissa Ruth Spears
Research Funding - Janssen-Cilag; Novartis; Pfizer; Sanofi
George N. Thalmann
No relevant relationships to disclose
Matthew Robert Sydes
Research Funding - Janssen-Cilag; Novartis; Pfizer; Sanofi